Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.
Wall Street Journal
The FDA also authorized a second Omicron-targeting booster shot for high-risk groups.
Understanding current events through the lenses of the past and future.
Wall Street Journal
The FDA also authorized a second Omicron-targeting booster shot for high-risk groups.